InterCure secures NIS 230 million settlement for war-related business disruption at Nir Oz facility
Reuters2026/08/24 11:03- InterCure reached a final settlement for war-related indirect damages totaling NIS 230 million, covering disruption from the Oct. 7, 2023 attacks.
- Canndoc’s main cultivation and production site at Kibbutz Nir Oz was severely damaged and rendered inoperable, pressuring output and results.
- Prior claim exceeded NIS 300 million; NIS 101 million had already been received as advance payments.
- Settlement funds are set to accelerate rehabilitation of the Nir Oz facility, targeting a return to full production.
- Restored capacity is expected to support expansion, with focus on supplying the German medical cannabis market.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y
As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
Crypto prices
More
